Literature DB >> 1342324

Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study.

L E Chambless1, R McMahon, K Wu, A Folsom, A Finch, Y L Shen.   

Abstract

Recent epidemiologic studies found that there is a strong association of hemostatic factors with ischemic heart disease. The Atherosclerosis Risk in Communities (ARIC) Intraindividual Variability (IIV) Study was conducted to estimate the various components of variation in hemostasis factors measured in the ARIC Study and to estimate the measures of repeatability of these factors. A total of 39 subjects (16 men, 23 women) were studied. Each had blood collected three times, with a 1- to 2-week interval between each visit. The contributions of between-person variability, within-person (biologic) variability, and processing and assay variability were estimated. Then the reliability coefficient R was estimated as the proportion of total variance accounted for by between-person variance. The reliability coefficient can be interpreted as the correlation between measures made at repeat visits. Among the various analytes, the reliability coefficients were quite high for activated partial thromboplastin time and plasma factor VIII (R = 0.92, 0.86, respectively). Low repeatability was obtained for antithrombin III activity and protein C (R = 0.42, 0.56, respectively). The lack of repeatability for these variables derives mostly from the processing (field center and laboratory) variation. Other analytes--fibrinogen, plasma factor VII, and von Willebrand factor--were intermediate in repeatability. In comparing the analyte-specific high-level to low-level groups, no substantial difference of within-person plus method coefficient of variation between the two groups was found for any analyte except for factor VIII, whereas the corresponding variance components for most analytes were higher for the higher analyte level. Reliability coefficients from this ARIC IIV study are generally higher than those found in other studies, and this is related to the relative variations in populations studied and to the time between measurements.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1342324     DOI: 10.1016/1047-2797(92)90017-k

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  26 in total

1.  Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.

Authors:  R K Linskens; A A van Bodegraven; M Schoorl; H A Tuynman; P Bartels
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.

Authors:  Weihong Tang; Saonli Basu; Xiaoxiao Kong; James S Pankow; Nena Aleksic; Adrian Tan; Mary Cushman; Eric Boerwinkle; Aaron R Folsom
Journal:  Blood       Date:  2010-08-27       Impact factor: 22.113

3.  Early-life and adult socioeconomic status and inflammatory risk markers in adulthood.

Authors:  Ricardo A Pollitt; Jay S Kaufman; Kathryn M Rose; Ana V Diez-Roux; Donglin Zeng; Gerardo Heiss
Journal:  Eur J Epidemiol       Date:  2007-01-17       Impact factor: 8.082

4.  Activated partial thromboplastin time and risk of future venous thromboembolism.

Authors:  Neil A Zakai; Tetsuya Ohira; Richard White; Aaron R Folsom; Mary Cushman
Journal:  Am J Med       Date:  2008-03       Impact factor: 4.965

5.  Thirty-year risk of ischemic stroke in individuals with sickle cell trait and modification by chronic kidney disease: The atherosclerosis risk in communities (ARIC) study.

Authors:  Melissa C Caughey; Vimal K Derebail; Nigel S Key; Alexander P Reiner; Rebecca F Gottesman; Abhijit V Kshirsagar; Gerardo Heiss
Journal:  Am J Hematol       Date:  2019-09-10       Impact factor: 10.047

6.  The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials.

Authors:  Penny M Kris-Etherton; Paul W Stewart; Henry N Ginsberg; Russell P Tracy; Michael Lefevre; Patricia J Elmer; Lars Berglund; Abby G Ershow; Thomas A Pearson; Rajasekhar Ramakrishnan; Stephen F Holleran; Barbara H Dennis; Catherine M Champagne; Wahida Karmally
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

7.  Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.

Authors:  Neil A Zakai; Pamela L Lutsey; Aaron R Folsom; Susan R Heckbert; Mary Cushman
Journal:  Thromb Haemost       Date:  2010-04-29       Impact factor: 5.249

8.  Analytical and biological variability in biomarker measurement in the Hispanic Community Health Study/Study of Latinos.

Authors:  Bharat Thyagarajan; Annie Green Howard; Ramon Durazo-Arvizu; John H Eckfeldt; Marc D Gellman; Ryung S Kim; Kiang Liu; Armando J Mendez; Frank J Penedo; Gregory A Talavera; Marston E Youngblood; Lihui Zhao; Daniela Sotres-Alvarez
Journal:  Clin Chim Acta       Date:  2016-10-15       Impact factor: 3.786

9.  Pleiotropic effects of n-6 and n-3 fatty acid-related genetic variants on circulating hemostatic variables.

Authors:  Lu-Chen Weng; Weihua Guan; Lyn M Steffen; James S Pankow; Nathan Pankratz; Ming-Huei Chen; Mary Cushman; Saonli Basu; Aaron R Folsom; Weihong Tang
Journal:  Thromb Res       Date:  2018-06-01       Impact factor: 3.944

10.  Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; T Ohira; K Yamagishi; M Cushman
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.